Table 5.
Model 1 | P value | Model 2 | P value | Model 3 | P value | |
---|---|---|---|---|---|---|
Age | 1.022 (0.955, 1.095) | 0.526 | 1.026 (0.954, 1.104) | 0.492 | ||
Female | 0.215 (0.040, 1.146) | 0.072 | 0.096∗ (0.013, 0.690) | 0.020 | ||
BMI | 0.935 (0.728, 1.201) | 0.598 | 0.866 (0.656, 1.144) | 0.311 | ||
Cigarette smoking | 0.627 (0.126, 3.117) | 0.569 | 0.698 (0.129, 3.770) | 0.676 | ||
HbA1C | 0.997 (0.659, 1.508) | 0.989 | 1.108 (0.697, 1.763) | 0.664 | ||
SBP | 1.411∗ (1.237, 1.609) | <0.00001 | 1.517∗ (1.274, 1.806) | <0.00001 | ||
TG | 0.985 (0.489, 1.984) | 0.966 | 0.885 (0.425, 1.842) | 0.743 | ||
HDL-C | 0.889 (0.064, 12.267) | 0.930 | 3.095 (0.164, 58.558) | 0.451 | ||
LDL-C | 0.776 (0.365, 1.650) | 0.510 | 0.513 (0.203, 1.296) | 0.158 | ||
Adiponectin | 0.474∗ (0.346, 0.648) | <0.00001 | 0.293∗ (0.113, 0.759) | 0.011 |
The odds ratio (OR) and 95% confidence interval of each parameter versus nondiabetic macroangiopathy participants were analyzed using binary logistic regression. Model 1 included traditional macrovascular risk factors such as age, sex, cigarette smoking, body mass index (BMI), HbA1C, systolic blood pressure (SBP), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) (n = 173, ∗P < 0.05). Model 2 included only adiponectin (n = 173, ∗P < 0.05). Model 3 incorporated Model 1 plus Model 2 (n = 173, ∗P < 0.05).